APA (7th ed.) Citation

RB, J., LR, S., PC, R., & R, F. (2026). CDK4/6 inhibitor-statin interaction and rhabdomyolysis in breast cancer treatment: A case-based systematic review. Cancer chemotherapy and pharmacology, 96(1), . https://doi.org/10.1007/s00280-026-04913-w

Chicago Style (17th ed.) Citation

RB, João, Soares LR, Ragazzo PC, and Freitas-Junior R. "CDK4/6 Inhibitor-statin Interaction and Rhabdomyolysis in Breast Cancer Treatment: A Case-based Systematic Review." Cancer Chemotherapy and Pharmacology 96, no. 1 (2026). https://doi.org/10.1007/s00280-026-04913-w.

MLA (9th ed.) Citation

RB, João, et al. "CDK4/6 Inhibitor-statin Interaction and Rhabdomyolysis in Breast Cancer Treatment: A Case-based Systematic Review." Cancer Chemotherapy and Pharmacology, vol. 96, no. 1, 2026, https://doi.org/10.1007/s00280-026-04913-w.